New cancer drug AB598 enters early human safety testing
NCT ID NCT05891171
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 19 times
Summary
This early-phase study tests the safety of a new drug called AB598, given alone or with other treatments, in about 40 people with advanced solid tumors (e.g., lung, bladder, breast, or ovarian cancer). The main goal is to see if the drug is safe and tolerable. Participants must have measurable tumors and be in relatively good health. This is not a cure but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adelaide Cancer Research
Adelaide, Australia
-
Affinity Health Hope and Healing Cancer Services, LLC
Hinsdale, Illinois, 60521, United States
-
Gabrail Cancer Center (GCC) Canton Facility
Canton, Ohio, 44718, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Lake City Cancer Care, LLC.
Lake City, Florida, 32024, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
National Cheng Kung University Hospital
Tainan, Taiwan
-
Next Oncology Dallas
Irving, Texas, 75039, United States
-
Next Oncology Virginia
Fairfax, Virginia, 22031, United States
-
Queen Elizabeth Hospital
Adelaide, Australia
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.